Aurinia Enhances Commercial and Business Development Expertise with the Appointment of Joseph P. Hagan to its Board of Directors Feb 8, 2018
Aurinia Pharmaceuticals Files New Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus Jan 4, 2018
Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights Nov 14, 2017
Aurinia Pharmaceuticals to Release Third Quarter 2017 Financial Results on November 14, 2017 Nov 6, 2017
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome Oct 20, 2017
Aurinia Receives National Corporate Visionary Award from the Lupus Foundation of America Oct 12, 2017
